Report #2828675

Received Feb 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 55 yrs
State: NV
Recovered: Unknown
Vaccinated: Jan 23, 2025
Onset: Jan 23, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	334T3	—

Symptoms (1)

Product preparation issue

Symptom narrative

adjuvant portion of the Shingrix vaccine was administered to a patient; adjuvant portion of the Shingrix vaccine was administered to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number 334T3, expiry date 29-OCT-2026) for prophylaxis. On 23-JAN-2025, the patient received Shingrix. On 23-JAN-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: adjuvant portion of the Shingrix vaccine was administered to a patient) and inappropriate dose of vaccine administered (Verbatim: adjuvant portion of the Shingrix vaccine was administered to a patient). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 10-FEB-2025 On 10th February 2025, reporter called to report that only the adjuvant portion of the Shingrix vaccine was administered to a patient on 23th January 2025, which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered.